Advertisement
Research Article| Volume 220, ISSUE 2, P448-453, August 2020

Download started.

Ok

Association of metabolic syndrome with morbidity and mortality in emergency general surgery

Published:December 21, 2019DOI:https://doi.org/10.1016/j.amjsurg.2019.12.021

      Highlights

      • Among EGS patients MetS increases morbidity and hospital readmission risk.
      • MetS had the strongest negative effect on appendectomy and increased mortality.
      • Specific complications to be expected are infective, renal, and pulmonary in nature.

      Abstract

      Background

      Metabolic syndrome (MetS) is defined by numerous comorbidities. We sought to assess MetS’s effect on the 7 main emergency general surgery (EGS) procedures that constitute 80% of EGS procedures, mortalities, complications, and costs.

      Methods

      Data were acquired from the ACS-NSQIP database from 2005 to 2017. Current procedural terminology (CPT) codes were utilized to identify cases. Patients with obesity, diabetes, and hypertension were defined as having MetS. MetS and non-MetS cohorts were propensity score matched, compared by outcomes, and assessed with multivariate logistic regression to attain odds ratios (OR).

      Results

      Of 752,023 cases, 41,788 (5.6%) MetS cases were identified. Significant outcomes included superficial infection (OR: 1.51), pulmonary complications (OR: 1.17), renal complications (OR: 1.82), cumulative morbidity (OR: 1.22), and hospital readmission (OR: 1.41).

      Conclusions

      For patients undergoing these procedures, MetS increased risk for comorbidities and hospital readmission. MetS had a significant impact on mortality only for appendectomy.

      Keywords

      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'

      Subscribe:

      Subscribe to The American Journal of Surgery
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect

      References

        • Norris P.
        • Ralph N.
        • Moloney C.
        Does metabolic syndrome predict surgical complications? A protocol for a systematic review and meta-analysis.
        Syst Rev. 2017; 6: 115
        • Apovian C.M.
        Obesity: definition, comorbidities, causes, and burden.
        Am J Manag Care. 2016; 22: s176-s185
        • Aguilar M.
        • et al.
        Prevalence of the metabolic syndrome in the United States, 2003-2012.
        Jama. 2015; 313: 1973-1974
        • Saklayen M.G.
        The global epidemic of the metabolic syndrome.
        Curr Hypertens Rep. 2018; 20: 12
        • Scott J.W.
        • et al.
        Use of national burden to define operative emergency general surgery.
        JAMA Surg. 2016; 151e160480
        • Gale S.C.
        • et al.
        The public health burden of emergency general surgery in the United States: a 10-year analysis of the Nationwide Inpatient Sample--2001 to 2010.
        J Trauma Acute Care Surg. 2014; 77: 202-208
        • Havens J.M.
        • et al.
        The excess morbidity and mortality of emergency general surgery.
        J Trauma Acute Care Surg. 2015; 78: 306-311
        • Brown C.V.
        • Velmahos G.C.
        The consequences of obesity on trauma, emergency surgery, and surgical critical care.
        World J Emerg Surg. 2006; 1: 27
        • Han T.S.
        • Lean M.E.
        A clinical perspective of obesity, metabolic syndrome and cardiovascular disease.
        JRSM Cardiovasc Dis. 2016; 5 (2048004016633371)
      1. Chung, A.S., et al., Metabolic syndrome and 30-day outcomes in elective lumbar spinal fusion. Spine, 2018. 43(9): p. 661-666.

        • Selph J.P.
        • et al.
        Metabolic syndrome as a predictor for postoperative complications after urologic surgery.
        Urology. 2014; 83: 1051-1059
        • Bhayani N.H.
        • et al.
        Effect of metabolic syndrome on perioperative outcomes after liver surgery: a National Surgical Quality Improvement Program (NSQIP) analysis.
        Surgery. 2012; 152: 218-226
        • Glance L.G.
        • et al.
        Perioperative outcomes among patients with the modified metabolic syndrome who are undergoing noncardiac surgery.
        Anesthesiology. 2010; 113: 859-872
        • Gonzalez Della Valle A.
        • et al.
        The metabolic syndrome in patients undergoing knee and hip arthroplasty: trends and in-hospital outcomes in the United States.
        J Arthroplast. 2012; 27: 1743-1749.e1
        • Surgeons A.C.o
        User Guide for the 2016 ACSNSQIP Participant Use Data File (PUF).
        2016 ([cited 2019; Available from:)
      2. Obesity: preventing and managing the global epidemic. Report of a WHO consultation.
        World Health Organ Tech Rep Ser. 2000; 894: 1-253
        • Grundy S.M.
        • et al.
        Diagnosis and management of the metabolic syndrome. An American heart association/national heart, lung, and blood institute scientific statement. Executive summary.
        Cardiol Rev. 2005; 13: 322-327
        • Armstrong R.A.
        When to use the Bonferroni correction.
        Ophthalmic Physiol Opt. 2014; 34: 502-508
        • Ansarimoghaddam A.
        • et al.
        Prevalence of metabolic syndrome in Middle-East countries: meta-analysis of cross-sectional studies.
        Diabetes Metab Syndr. 2018; 12: 195-201
        • Scuteri A.
        • et al.
        Metabolic syndrome across Europe: different clusters of risk factors.
        Eur J Prev Cardiol. 2015; 22: 486-491
        • Moore J.X.
        • Chaudhary N.
        • Akinyemiju T.
        Metabolic syndrome prevalence by race/ethnicity and sex in the United States, national health and nutrition examination survey, 1988-2012.
        Prev Chronic Dis. 2017; 14: E24
        • Pucci G.
        • et al.
        Sex- and gender-related prevalence, cardiovascular risk and therapeutic approach in metabolic syndrome: a review of the literature.
        Pharmacol Res. 2017; 120: 34-42
        • Shapo L.
        • Pomerleau J.
        • McKee M.
        Epidemiology of hypertension and associated cardiovascular risk factors in a country in transition: a population based survey in Tirana City, Albania.
        J Epidemiol Community Health. 2003; 57: 734-739
        • Mills K.T.
        • et al.
        Global disparities of hypertension prevalence and control: a systematic analysis of population-based studies from 90 countries.
        Circulation. 2016; 134: 441-450
        • Forouhi N.G.
        • Wareham N.J.
        Epidemiology of diabetes.
        Medicine. 2014; 42: 698-702
        • O’Neill S.
        • O’Driscoll L.
        Metabolic syndrome: a closer look at the growing epidemic and its associated pathologies.
        Obes Rev. 2015; 16: 1-12
        • Oh S.W.
        • et al.
        Association between cigarette smoking and metabolic syndrome: the korea national health and nutrition examination survey.
        Diabetes Care. 2005; 28: 2064-2066
        • Ozkan S.
        • et al.
        The effects of the metabolic syndrome on coronary artery bypass grafting surgery.
        Cardiovasc J Afr. 2017; 28: 48-53
        • Malik A.T.
        • et al.
        The impact of metabolic syndrome on 30-day outcomes in geriatric hip fracture surgeries.
        Eur J Orthop Surg Traumatol. 2019; 29: 427-433
        • Lovecchio F.
        • et al.
        Does obesity explain the effect of the metabolic syndrome on complications following elective lumbar fusion? A propensity score matched analysis.
        Glob Spine J. 2018; 8: 683-689
        • Chen Y.
        • Wu S.
        • Tian Y.
        Cholecystectomy as a risk factor of metabolic syndrome: from epidemiologic clues to biochemical mechanisms.
        Lab Investig. 2018; 98: 7-14
        • Garruti G.
        • et al.
        Cholecystectomy: a way forward and back to metabolic syndrome?.
        Lab Investig. 2018; 98: 4-6
        • Di Ciaula A.
        • et al.
        Cholecystectomy and risk of metabolic syndrome.
        Eur J Intern Med. 2018; 53: 3-11
        • Choi B.J.
        • et al.
        Impact of obesity on the short-term outcomes of single-port laparoscopic colectomy for colorectal cancer in the Asian population: a retrospective cohort study.
        Medicine (Baltim). 2017; 96: e6649
        • Pi-Sunyer X.
        The medical risks of obesity.
        PGM (Postgrad Med). 2009; 121: 21-33
        • Huber T.
        • et al.
        [Appendectomy in surgical residency. What has changed over the past 10 years?].
        Chirurg. 2016; 87: 326-331
        • Lasek A.
        • et al.
        The significant impact of age on the clinical outcomes of laparoscopic appendectomy: results from the Polish Laparoscopic Appendectomy multicenter large cohort study.
        Medicine (Baltim). 2018; 97e13621